Renal Outcome in Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass

被引:2
|
作者
Alqarni, Mohammed S. [1 ]
Ghunaim, Abdullah H. [2 ]
Abukhodair, Abdulkarim W. [1 ]
Fernandez, Jose Andres [3 ]
Bennett, Sean R. [3 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Med, Jeddah, Saudi Arabia
[2] King Abdulaziz Univ, Coll Med, Med, Jeddah, Saudi Arabia
[3] King Abdullah Med City, King Faisal Cardiac Ctr, Anesthesiol, Jeddah, Saudi Arabia
关键词
renal outcome; cardiac surgery; cardiopulmonary bypass; kingdom of saudi arabia (ksa); CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; GLOBAL BURDEN; RISK; DURATION;
D O I
10.7759/cureus.9015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Renal dysfunction is a significant variable in determining the outcome of surgery, such as cardiopulmonary bypass graft and valvular replacement, used to treat cardiovascular diseases. In Saudi Arabia, the incidence of renal failure and diabetes is higher than in most western populations. Our aim is to determine the renal outcome of patients who underwent cardiac surgery at King Faisal Cardiac Center from 2014 to 2017. Methods This a retrospective cohort study using a non-probability consecutive sampling technique for selection of the study population to assess the renal outcome in cardiac surgery patients using cardiopulmonary bypass from May 2014 to June 2017 in King Faisal Cardiac Center, Jeddah. Patients older than 18 years of age undergoing cardiac surgery, with available data, were included. Categorical variables were summarized by percentages and frequencies, and continuous variables by means and standard deviations, or medians and interquartile ranges if their distributions were skewed. Logistic regression was done with post-op renal impairment as the dependent variable and pre-op renal dysfunction, age, gender, smoking status, diabetes, hypertension, dyslipidemia, and cardiopulmonary bypass time as independent variables. Results Our sample size included 244 patients who underwent cardiac surgery in this study period; their mean age was 60.5 (SD =7.5) with a mean body mass index (BMI) of 28.62 (SD=5.19). Among our population, 73% (n = 179) were males and 27% (n =66) were females. Two percent (2%) of patients (n = 5) died within 30 days, 4% of patients (n = 10) with temporary dialysis, 8% of patients (n = 19) with postoperative renal dysfunction, and no patients with permanent dialysis. The data showed a significant relationship between levels of creatinine preoperatively and postoperative renal dysfunction (p-value = 0.0001, OR=1.05, 95% CI of 1.031 to 1.064). Conclusion The main predictor of poor renal outcomes for cardiac surgery is preoperative creatinine. While other factors, such as age, gender, body mass index, cardiopulmonary bypass time, diabetes, hypertension, and dyslipidemia, did not show any risk to the postoperative renal outcome.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Renal function in patients undergoing cardiopulmonary bypass for open cardiac surgical procedures
    Ahmad, Irshad
    Bhat, Mubasher Ahmad
    Bhat, Abdul Wahid
    Ommid, Mohamad
    Gani, Tanveera
    Nisa, Gousia
    SRI LANKAN JOURNAL OF ANAESTHESIOLOGY, 2013, 21 (01): : 20 - 26
  • [22] Pharmacokinetics and metabolic effects of dichloroacetate in patients undergoing cardiac surgery with cardiopulmonary bypass
    Shangraw, RE
    Davis, RF
    ANESTHESIA AND ANALGESIA, 1998, 86 (2S):
  • [23] Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass*
    Sharma, V.
    Fan, J.
    Jerath, A.
    Pang, K. S.
    Bojko, B.
    Pawliszyn, J.
    Karski, J. M.
    Yau, T.
    McCluskey, S.
    Wasowicz, M.
    ANAESTHESIA, 2012, 67 (11) : 1242 - 1250
  • [24] Levels of Circulating Ketone Bodies in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass
    Levis, Anja
    Huber, Markus
    Mathis, Deborah
    Filipovic, Mark G.
    Stieger, Andrea
    Raber, Lorenz
    Stueber, Frank
    Luedi, Markus M.
    CELLS, 2024, 13 (04)
  • [25] Cerebral hyperthermia during cardiopulmonary bypass rewarming in patients undergoing cardiac surgery
    Yao, FSF
    Barbut, D
    Leon, EJ
    Trifiletti, RR
    DeBois, WJ
    Purcell, MH
    Hartman, GS
    ANESTHESIOLOGY, 1998, 89 (3A) : U255 - U255
  • [26] Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass
    Madhivathanan, Pradeep R.
    Fletcher, Nick
    Gaze, David
    Thomson, Rebekah
    Chandrasekaran, Venkatachalam
    Al-Subaie, Nawaf
    Valencia, Oswaldo
    Sharma, Vivek
    CYTOKINE, 2016, 83 : 8 - 12
  • [27] Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery
    García, MPO
    Martí-Bonmatí, E
    Serrano, JG
    Gómez, IG
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (03) : 260 - 265
  • [28] Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass
    Puri, GD
    Murthy, SS
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2003, 20 (06) : 451 - 456
  • [29] Cardiac surgery, cardiopulmonary bypass, and preoperative renal dysfunction
    Lema, G.
    Urzua, J.
    Jalil, R.
    Canessa, R.
    BRITISH JOURNAL OF ANAESTHESIA, 2008, 101 (03) : 429 - 429
  • [30] NEUROLOGICAL OUTCOME IN PATIENTS SUBJECTED TO CARDIAC-SURGERY WITH AND WITHOUT CARDIOPULMONARY BYPASS
    MALHEIROS, SMF
    BRUCKI, SMD
    BERTOLUCCI, PHF
    MASSARO, AR
    GABBAI, AA
    JULIANO, Y
    ANDRADE, JCS
    CARVALHO, ACC
    BUFFOLO, E
    NEUROLOGY, 1993, 43 (04) : A375 - A375